BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 5539356)

  • 1. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW; McEvoy D; Wallach EE
    Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
    [No Abstract]   [Full Text] [Related]  

  • 2. Hirsutism and evaluation of the dexamethasone suppression and chorionic gonadotropin stimulation test.
    Lopez JM; Migeon CJ; Jones GE
    Am J Obstet Gynecol; 1967 Jul; 98(6):749-58. PubMed ID: 6027702
    [No Abstract]   [Full Text] [Related]  

  • 3. [Has suppression of the adrenal function with dexamethasone and stimulation of the ovarian function with pregnyl (Netter's test) any significance for the surgical indication of ovarian resection?].
    Hart PG; van der Molen HJ; Bakker JH
    Ned Tijdschr Verloskd Gynaecol; 1968 Feb; 68(1):1-20. PubMed ID: 5653515
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of wedged ovarian excision on steroid excretion in the hirsutic woman].
    Guadalix FJ; Bagazgoitia FJ; Ruiz MC; Botella Llusiá J
    Acta Ginecol (Madr); 1974 Feb; 25(2):141-56. PubMed ID: 4411144
    [No Abstract]   [Full Text] [Related]  

  • 5. Virilization in pregnancy associated with polycystic ovary disease.
    Fayez JA; Bunch TR; Miller GL
    Obstet Gynecol; 1974 Oct; 44(4):511-21. PubMed ID: 4370552
    [No Abstract]   [Full Text] [Related]  

  • 6. The significance of the combined dexamethasone-HCG test for the assessment of hyperandrogenism.
    Varga L; Azokwu P
    Acta Eur Fertil; 1976 Dec; 7(4):267-79. PubMed ID: 1025999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hirsutism: metabolic and clinical problems].
    Modignani RL
    Folia Endocrinol; 1971; 24(5):385-92. PubMed ID: 5172227
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamic functional tests for differential diagnosis of hirsutism: contribution to the standardization of the method].
    D'Alessandro B; Bellastella A; Esposito V; Iacono G
    Boll Soc Ital Biol Sper; 1967 Sep; 43(18):1123-5. PubMed ID: 6073059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hirsutism].
    Laatikainen T
    Duodecim; 1975; 91(7):483-90. PubMed ID: 166814
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new combined test of ovarian inhibition and adrenal stimulation: behavior of urinary total and fractionated 17-KS, of 17-hydroxycorticoids, pregnanediol and pregnanetriol].
    Bellastella A; D'Alessandro B; Gasbarro R; Iacono G
    Folia Endocrinol; 1969 Dec; 22(4):498-504. PubMed ID: 4329094
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination of ACTH dexamethazone and HCG in the differential diagnosis of hirsutism and polycystic ovaries (author's transl)].
    Divila F; Presl J; Stroufová A; Kozlová J; Horský J
    Cesk Gynekol; 1973 Sep; 38(8):627-9. PubMed ID: 4358102
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma testosterone stimulation-suppression dynamics in hirsute women.
    Ettinger B; Von Werder K; Thenaers GC; Forsham PH
    Am J Med; 1971 Aug; 51(2):170-5. PubMed ID: 4328775
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of the dexamethasone-mestranol-HCG test for the differential diagnosis of forms of hirsutism].
    Wodrig W; Kother T
    Zentralbl Gynakol; 1985; 107(14):883-8. PubMed ID: 4036406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adrenal cortex and ovarian intervention in the pathogenesis of minor hyperandrogenism. I. Study of fractionated urinary 17-ketosteroids in basal and dynamic conditions in 30 women with hirsutism].
    Minozzi M; Faggiano M; Salerno M; Orio F; Lombardi G; Jori JP
    Folia Endocrinol; 1967 Dec; 20(6):736-64. PubMed ID: 4303786
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical value of the dexamethasone-HCG test in females with hirsutism with special reference to 17-beta-hydroxyandrogens].
    Häffele R; Lüdtke E; König A
    Zentralbl Gynakol; 1978; 100(10):618-27. PubMed ID: 676562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian hyperthecosis in the adolescent patient.
    Wentz AC; Gutai JP; Jones GS; Migeon CJ
    J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The urinary elimination of 17-hydroxycorticosteroids and 17-ketosteroids in some dynamico-idiopathic functional tests in simple obesity, hirsutism and ovarian polycystic disease].
    Lodeserto A; Reschini E; Giustina G
    Arch Maragliano Patol Clin; 1968; 24(4):443-55. PubMed ID: 4303680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiopathogenesis of the polycystic ovary syndrome].
    Pelocchino AM; Montalenti D
    Minerva Med; 1973 Apr; 64(29):1530-42. PubMed ID: 4713748
    [No Abstract]   [Full Text] [Related]  

  • 19. Stein-Leventhal syndrome in a 12-year-old girl.
    Olambiwonnu NO; Wilkinson R; Penny R; Frasier SD
    Am J Dis Child; 1974 Feb; 127(2):279-80. PubMed ID: 4359096
    [No Abstract]   [Full Text] [Related]  

  • 20. The origin of androgen synthesis in polycystic ovary syndrome.
    Milewicz A; Silber D; Mielecki T
    Obstet Gynecol; 1983 Nov; 62(5):601-4. PubMed ID: 6225965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.